Studying Clinical Frailty as a Risk Factor for Death in Adults Aged 18 to 65 with Septic Shock in Intensive Care

What this Trial Is About

This research aims to understand how clinical frailty affects adults aged 18 to 65 admitted to intensive care for septic shock. It focuses on whether patients classified as frail or severely frail using the Clinical Frailty Scale CFS face higher risks of death, longer hospital stays, increased readmission rates, and poorer quality of life. The study seeks to improve predictions and care decisions for critically ill younger patients with sepsis. The study observes patients admitted for suspected or confirmed type 3 sepsis who require vasopressor support to maintain blood pressure and have elevated lactate levels. There are no experimental treatments or interventions instead, this observational study collects data on patients frailty scores and their health outcomes over time. Participants will be closely monitored for 28 and 90 days after admission to evaluate mortality risk, length of hospital stay, use of invasive therapies, and readmission rates. Researchers will also assess changes in frailty and quality of life at 90 days. This detailed follow-up helps clarify the impact of frailty on recovery and survival, aiding better care planning and communication with patients and families.

Evaluation of the Clinical Frailty Scale (CFS) as a Risk Factor of Mortality in Adult Patients ≤65 Years of Age Admitted to Intensive Care for Septic Shock.